The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
Shinji Iwasaki(Kochi Medical School Hospital), Gotaro Toda, Mikio Zeniya(International University of Health and Welfare), Hiromi Ishibashi(Nagasaki Medical Center), Shigeki Kuriyama(Kagawa University), Shuichi Kaneko(Kanazawa University Hospital), Isao Sakaida(Yamaguchi University), Shuhei Nishiguchi(Osaka City University), Saburo Onishi(Kochi Medical School Hospital), Morikazu Onji(Ehime University), Takafumi Ichida(Nagoya City University), Hiromasa Ohira(Fukushima Medical University)
Cited by 142
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan
|Hepatology|2001|418
A Case–Control Study for Clinical and Molecular Biological Differences Between Hepatitis B Viruses of Genotypes B and C
|Hepatology|2001|396
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|271